Vivimed Labs Limited (VIVIMEDLAB) — Announcement | 17 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Sixth Committee of Creditors meeting scheduled for August 18, 2026
💡 Investor Takeaway
This meeting may influence the restructuring path and creditor recovery rates.

Vivimed Labs Limited announced a pre-filing notice of its sixth Committee of Creditors meeting scheduled for August 18, 2026, under its ongoing corporate insolvency resolution process initiated by NCLT order on April 15, 2026. The filing complies with SEBI Listing Obligations and Disclosure Requirements. This step reflects the company's structured progression through insolvency proceedings, signaling active creditor engagement and potential restructuring outcomes for stakeholders.

📄 View Original Announcement (PDF)

About Vivimed Labs Limited (VIVIMEDLAB)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹57.46 Cr ROE: 501.8% ROCE: -50.5%

View full VIVIMEDLAB stock details →

📡 Get AI alerts when VIVIMEDLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIVIMEDLAB — Free

📊 More VIVIMEDLAB filings

See all VIVIMEDLAB filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when VIVIMEDLAB files new disclosures

Track VIVIMEDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIVIMEDLAB — Free

Free account · 2 AI queries/day